Form 4 for IDXX Idexx Laboratories
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0000874716-24-000128 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-04 | 2024-09-01 | IDXX | Smith Martin Alexander | EVP | M - OptEx | $0.00 | +18 | 514.95 | +4% | $0 |
| D | 2024-09-04 | 2024-09-01 | IDXX | Smith Martin Alexander | EVP | F - Tax | $481.33 | -5 | 509.95 | -1.0% | -$2,407 |
| D | 2024-09-04 | 2024-09-01 | IDXX | Smith Martin Alexander | EVP | M - OptEx | — | -18 | 18 | -50% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-01 | M | A | 18 | $0.00 | 514.95 | D | — | — | (F1) Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024. |
| 2 | Common | Common Stock | 2024-09-01 | F | D | 5 | $481.33 | 509.95 | D | — | — | (F2) Closing price of Issuer common stock on August 30, 2024. |
| 3 | Derivative | Restricted Stock Unit | 2024-09-01 | M | D | 18 | — | 18 | D | — · — to — | 18 Common Stock | (F4) Not applicable. (F3) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022. |